Beginning Cash: The amount of cash reported by the company on its previous statement.
Tenax Therapeutics, Inc. (TENX) had Beginning Cash of $94.85M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-15.54M |
|
-- |
|
-- |
|
$16.45M |
|
$-16.45M |
|
$0.91M |
|
$-15.54M |
|
$-15.54M |
|
$-15.54M |
|
$-15.54M |
|
$-15.54M |
|
$-15.54M |
|
$-16.45M |
|
$-16.45M |
|
39.22M |
|
39.22M |
|
$-0.39 |
|
$-0.39 |
|
| Balance Sheet Financials | |
$104.23M |
|
-- |
|
-- |
|
$104.23M |
|
$7.16M |
|
-- |
|
-- |
|
$7.16M |
|
$97.07M |
|
$97.07M |
|
$97.07M |
|
9.31M |
|
| Cash Flow Statement Financials | |
$-35.80M |
|
-- |
|
$38.51M |
|
|
Beginning Cash |
$94.85M |
$97.56M |
|
$2.71M |
|
$19.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.56 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-35.80M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.01% |
|
-16.01% |
|
-14.91% |
|
-16.01% |
|
$10.42 |
|
$-0.91 |
|
$-0.91 |
|